CD44 antibody–mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruption

Publisher： John Wiley & Sons Inc

E-ISSN： 1537-2995|55|6pt2|1492-1500

ISSN： 0041-1132

Source： TRANSFUSION, Vol.55, Iss.6pt2, 2015-06, pp. : 1492-1500

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti‐huCD20 Antibody Therapy for Antibody‐Mediated Rejection of Renal Allografts in a Mouse Model

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 5, 2015-05 ,pp. : 1192-1204

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Regulatory FcγR System in Antibody-Mediated Autoimmune Diseases

By  

Transfusion Medicine and Hemotherapy, Vol. 31, Iss. 2, 2004-04 ,pp. : 74-82

Karger

Access to resources Recommend Favorite

Sports Participation in Children and Adolescents with Immune Thrombocytopenia (ITP)

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 12, 2015-12 ,pp. : 2223-2225

John Wiley & Sons Inc

Access to resources Recommend Favorite

Improved FcγRIIb Targeting Functionally Translates into Enhanced Inhibition of Basophil Activation

By  

International Archives of Allergy and Immunology, Vol. 163, Iss. 3, 2014-02 ,pp. : 206-214

Karger

Access to resources Recommend Favorite

A monoclonal antibody with anti‐D–like activity in murine immune thrombocytopenia requires Fc domain function for immune thrombocytopenia ameliorative effects

By  

TRANSFUSION, Vol. 55, Iss. 6pt2, 2015-06 ,pp. : 1501-1511

John Wiley & Sons Inc

Access to resources Recommend Favorite